These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36217367)

  • 21. The effects of ART on the dynamics of lipid profiles in Chinese Han HIV-infected patients: comparison between NRTI/NNRTI and NRTI/INSTI.
    Liu S; Wei B; Liang W; Chen T; Deng L; Zhao M; Wan J
    Front Public Health; 2023; 11():1161503. PubMed ID: 37181701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between hemoglobin A1c and serum lipid profile in Afghani patients with type 2 diabetes: hemoglobin A1c prognosticates dyslipidemia.
    Hussain A; Ali I; Ijaz M; Rahim A
    Ther Adv Endocrinol Metab; 2017 Apr; 8(4):51-57. PubMed ID: 28507727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of dyslipidemia associated with complications in diabetic patients: a nationwide study in Thailand.
    Narindrarangkura P; Bosl W; Rangsin R; Hatthachote P
    Lipids Health Dis; 2019 Apr; 18(1):90. PubMed ID: 30954084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Albuminuria status and patterns of dyslipidemia among type 2 diabetes black patients managed at a tertiary health-care hospital: A
    Kajingulu FM; Lepira FB; Mbutiwi FI; Makulo JR; Sumaili EK; Bukabau JB; Mokoli VM; Longo AL; Nseka NM
    Saudi J Kidney Dis Transpl; 2018; 29(3):649-657. PubMed ID: 29970743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.
    Erem C; Hacihasanoglu A; Deger O; Kocak M; Topbas M
    Endocrine; 2008; 34(1-3):36-51. PubMed ID: 19003544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study.
    Ozder A
    Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiometabolic Risk Factors Associated With Type 2 Diabetes Mellitus: A Mechanistic Insight.
    Chakraborty S; Verma A; Garg R; Singh J; Verma H
    Clin Med Insights Endocrinol Diabetes; 2023; 16():11795514231220780. PubMed ID: 38148756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of dyslipidemia and factors affecting lipid profile in patients with type 2 diabetes.
    Shahwan MJ; Jairoun AA; Farajallah A; Shanabli S
    Diabetes Metab Syndr; 2019; 13(4):2387-2392. PubMed ID: 31405648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of HbA1c Level with Lipid Profile in Type 2 Diabetes Mellitus Patients Visiting a Primary Healthcare Center in Jeddah City, Saudi Arabia: A Retrospective Cross-Sectional Study.
    Sharahili AY; Mir SA; ALDosari S; Manzar MD; Alshehri B; Al Othaim A; Alghofaili F; Madkhali Y; Albenasy KS; Alotaibi JS
    Diseases; 2023 Oct; 11(4):. PubMed ID: 37987265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol.
    Colhoun HM; Leiter LA; Müller-Wieland D; Cariou B; Ray KK; Tinahones FJ; Domenger C; Letierce A; Israel M; Samuel R; Del Prato S
    Cardiovasc Diabetol; 2020 Feb; 19(1):14. PubMed ID: 32035487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycemic control and diabetic dyslipidemia in adolescents with type 2 diabetes.
    Le PT; Huisingh CE; Ashraf AP
    Endocr Pract; 2013; 19(6):972-9. PubMed ID: 23807519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Dyslipidemia with Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients: A Hospital-Based Study.
    Ezhilvendhan K; Sathiyamoorthy A; Prakash BJ; Bhava BS; Shenoy A
    J Pharm Bioallied Sci; 2021 Nov; 13(Suppl 2):S1062-S1067. PubMed ID: 35017930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and pattern of dyslipidemia in patients with type 2 diabetes mellitus in Zaria, Northwestern Nigeria.
    Bello-Ovosi BO; Ovosi JO; Ogunsina MA; Asuke S; Ibrahim MS
    Pan Afr Med J; 2019; 34():123. PubMed ID: 33708292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.
    Pérez A; Wägner AM; Carreras G; Giménez G; Sánchez-Quesada JL; Rigla M; Gómez-Gerique JA; Pou JM; de Leiva A
    Arch Intern Med; 2000 Oct; 160(18):2756-62. PubMed ID: 11025785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dyslipidemia and Its Associated Risk Factors Among Adult Type-2 Diabetic Patients at Jimma University Medical Center, Jimma, Southwest Ethiopia.
    Haile K; Timerga A
    Diabetes Metab Syndr Obes; 2020; 13():4589-4597. PubMed ID: 33273834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China.
    Yang T; Liu Y; Li L; Zheng Y; Wang Y; Su J; Yang R; Luo M; Yu C
    Cardiovasc Diabetol; 2022 Jun; 21(1):93. PubMed ID: 35659300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid Profile and the Frequency of Dyslipidemia in Iranian Adolescents with Severe Obesity, Who Were Candidates for Bariatric Surgery.
    Soheilipour F; Geram F
    Obes Surg; 2024 Feb; 34(2):618-624. PubMed ID: 38191967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevalence trends and related factors of hypertension patients complicating with dyslipidemia in community of Guandong province between 2013 and 2018].
    Huang YQ; Li J; Chen JY; Feng YQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Oct; 49(10):986-992. PubMed ID: 34674436
    [No Abstract]   [Full Text] [Related]  

  • 39. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence, pattern, and correlates of dyslipidemia in Bangladeshi individuals.
    Islam MT; Samad Talha MTU; Shafiq SS; Mazumder T; Gupta RD; Siraj MS
    J Clin Lipidol; 2023; 17(6):788-799. PubMed ID: 37743185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.